Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19
Philippe Bégin(Université de Montréal), Makeda Semret(McGill University Health Centre), Lisa Schwartz(Impact), Dana V. Devine(University of British Columbia), Holly Carr(Sunnybrook Health Science Centre), Allison McGeer(Sinai Hospital), Melissa M. Cushing(NewYork–Presbyterian Hospital), Nick Daneman(Institute of Health Services and Policy Research), Guillaume Beaudoin-Bussières(Centre Hospitalier de l’Université de Montréal), Jeannot Dumaresq(Centre intégré de santé et de services sociaux de Chaudière-Appalaches), Erin Jamula(McMaster University), Yulia Lin(Sunnybrook Health Science Centre), Yang Liu(The University of Texas Medical Branch at Galveston), Marshall J. Glesby, Nadine Shehata(Mount Sinai Hospital), Bruce S. Sachais(New York Blood Center), Christopher D. Graham(NHS Lothian), Ryan Zarychanski(CancerCare Manitoba), Danièle Marceau(NewYork–Presbyterian Brooklyn Methodist Hospital), Christine Arsenault(Markham Stouffville Hospital), Nancy Robitaille(Héma-Québec), Richard J. Cook(University of Waterloo), Andy C. Huang(NewYork–Presbyterian Brooklyn Methodist Hospital), Renée Bazin(World Health Organization Regional Office for South-East Asia), Rosemarie Lall(The Scarborough Hospital), Caroline Gabe(Cornell University), Dean Fergusson(Ottawa Hospital), Alexis F. Turgeon(Université Laval), Michelle P. Zeller(Canadian Blood Services), Heidi Wood(Public Health Agency of Canada), Alan Tinmouth(Center for Biologics Evaluation and Research), Davinder Sidhu(McGill University Health Centre), Richard Carl, Kent Cadogan Loftsgard, Damon C. Scales(Health Sciences Centre), Na Li(University of Calgary), Jeannie Callum(Sunnybrook Health Science Centre), Luiz Amorim(Héma-Québec), Jeannie Callum(Sunnybrook Health Science Centre), Valérie Sales(Markham Stouffville Hospital), Michaël Chassé, Andrés Finzi(Centre Hospitalier de l’Université de Montréal), Nancy M. Heddle(McMaster University)
Cited by 1
Related Papers
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
|JAMA|2015|2.5k
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
|Cochrane Database of Systematic Reviews|2016|1.2k
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
|New England Journal of Medicine|2018|1.2k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k